Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study

Fig. 1

Kaplan–Meier estimation curves of cumulative incidences of adverse outcomes all-cause mortality (a); cardiovascular mortality (b); major adverse cardiovascular events (c); and total cardiovascular events (d), for patients divided into tertiles (T1, lowest; T2, middle; T3 highest) of the neutrophyl-to-lymphocyte ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840